Core Viewpoint - Zhejiang Hengtong Holdings Co., Ltd. is currently involved in litigation against Berry Dawn Media Investment Center (Limited Partnership) regarding the return of transaction intention funds and associated penalties, with the case in the execution phase [2][3]. Group 1: Litigation Details - The company is the plaintiff in two lawsuits against Berry Dawn, seeking the return of transaction intention funds totaling 500 million yuan and 229.3 million yuan, along with associated fees and penalties [3][4][5][6]. - The total amount involved in the first case is 285,256,321.92 yuan, which includes the return of 50 million yuan, usage fees of 67,460,021.92 yuan, and a penalty of 167,796,300 yuan [3][4]. - In the second case, the company seeks the return of 22,930 million yuan and additional fees calculated at an annual interest rate of 8% and a daily penalty rate of 0.05% [4][6]. Group 2: Court Rulings and Execution Progress - The company won the first lawsuit, with the court ruling in its favor, and the judgment became effective after the withdrawal of the appeal by Berry Dawn [7]. - The second lawsuit also resulted in a favorable ruling for the company, which has been confirmed as effective [7]. - As of November 20, 2025, the court has conducted public auctions of properties owned by the defendants, with one property sold for 701,000 yuan [9]. Group 3: Financial Impact - As of December 31, 2024, the company has recorded accounts receivable from Berry Dawn totaling 266.2 million yuan, with an equivalent provision for bad debts [11]. - The company has received 21.38 million yuan from the execution of the lawsuits, and the impact on current and future profits will depend on the execution status of the lawsuits [11].

浙江亨通控股股份有限公司 诉讼进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：600226 证券简称：亨通股份 公告编号：2025-053 涉案金额：案件一：宁波梅山保税港区浆果晨曦新媒体投资中心(有限合伙)(以 下简称"浆果晨曦")应向公司返还第二期交易意向金 5,000 万元、支付资金使用费 67,460,021.92 元、支付违约金 167,796,300.00 元，合计 285,256,321.92 元（资金使 用费、违约金暂计至 2021 年 12 月 31 日），喻策对浆果晨曦的上述付款义务承担连带 清偿责任，承担连带责任后有权向浆果晨曦追偿。公司有权在 285,256,321.92 元范围 内，就浆果晨曦质押给公司的其持有的深圳量子云科技有限公司（以下简称"量子云"） 名下 75.5%股权（质权登记编号：202006083227）折价或者拍卖、变卖所得价款优先受 偿。 案件二：浆果晨曦向公司返还剩余交易意向金22,930万元及资金使用费（以27,930 万元为基数，自 2022 ...

Group 1 - The animal vaccine concept index rose by 0.33%, ranking 8th among concept sectors, with 6 stocks increasing in value, including Xianfeng Holdings which hit the daily limit, and others like Ronow Mountain, Hengtong Co., and Biological Shares showing gains of 7.27%, 3.99%, and 1.98% respectively [1] - The animal vaccine sector saw a net inflow of 222 million yuan from main funds, with Ronow Mountain leading the inflow at 157 million yuan, followed by Xianfeng Holdings, Hengtong Co., and Biological Shares with net inflows of 124 million yuan, 37.45 million yuan, and 15.21 million yuan respectively [2][3] - The top stocks in terms of net inflow ratio included Xianfeng Holdings at 26.79%, Ronow Mountain at 13.84%, and Hengtong Co. at 8.61% [3] Group 2 - The stocks with the largest declines included Yongshun Biological, Shenlian Biological, and Tiankang Biological, which fell by 4.51%, 2.08%, and 1.86% respectively [1] - Other stocks in the animal vaccine sector that experienced declines included Kexing Pharmaceutical, with a decrease of 0.60%, and Zhongmu Co., which fell by 1.13% [4] - The overall trading activity in the animal vaccine sector showed varied turnover rates, with Ronow Mountain at 11.47% and Xianfeng Holdings at 11.16% [3]

Core Viewpoint - The company has provided guarantees for its wholly-owned subsidiaries, Hengtong Precision Copper Foil Technology (Deyang) Co., Ltd. and Zhejiang Baike Biotechnology Co., Ltd., to support their operational funding needs through loans from banks [2][9]. Group 1: Guarantee Details - The company signed a guarantee contract with Bank of China Chengdu Longquanyi Branch to provide a joint liability guarantee for a loan of RMB 100 million (10,000 million) for Hengtong Copper Foil [2][7]. - A maximum guarantee contract was signed with Jiaxing Bank Anji Branch for a credit of RMB 50 million (5,000 million) for Baike Biotechnology [2][8]. - The guarantee period for both contracts is three years from the maturity of the debt [7][8]. Group 2: Internal Decision-Making Process - The company's board of directors and the fourth extraordinary general meeting of shareholders approved the proposal to provide guarantees for the subsidiaries, with authorized limits of RMB 900 million (90,000 million) for Hengtong Copper Foil and RMB 300 million (30,000 million) for Baike Biotechnology [3][10]. - The guarantees fall within the limits approved by the shareholders' meeting, eliminating the need for additional board or shareholder meetings [4]. Group 3: Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary to meet the operational funding needs of the subsidiaries and to facilitate the company's transformation and development [9]. - The subsidiaries are reported to have normal operations and good credit status, making the risks associated with the guarantees controllable [9][11]. Group 4: Cumulative Guarantee Situation - As of the announcement date, the total amount of external guarantees provided by the company and its subsidiaries is RMB 436.6458 million (43,664.58 million), accounting for 12.79% of the company's audited net assets for 2024 [11]. - The actual guarantee amount for Hengtong Copper Foil is RMB 386.6458 million (38,664.58 million), representing 11.32% of the company's audited net assets, while for Baike Biotechnology, it is RMB 50 million (5,000.00 million), accounting for 1.46% [11].

Group 1 - The company, Hengtong Optic-electric Co., Ltd., announced that it does not have any overdue guarantees [2]

证券代码：600226 证券简称：亨通股份 公告编号：2025-052 浙江亨通控股股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 （一）担保的基本情况 为保证全资子公司亨通精密铜箔科技（德阳）有限公司（以下简称"亨通铜 箔"）经营发展资金需求，浙江亨通控股股份有限公司（以下简称"公司"）于近 日与中国银行股份有限公司成都龙泉驿支行（以下简称"中行龙泉驿支行"）签 署了《保证合同》（编号：2025 年 HTKG 保字第 003 号），为亨通铜箔向中行龙泉 驿支行申请的流动资金贷款 10,000.00 万元提供连带责任担保。本次担保期限为 债务履行期限届满之日起三年，上述担保不存在反担保。 为保证全资子公司浙江拜克生物科技有限公司（以下简称"拜克生物"）经 营发展资金需求，公司于近日与嘉兴银行股份有限公司湖州安吉支行（以下简称 "嘉兴银行安吉支行"）签署了《最高额保证合同》（编号：2025111800000174）， 为拜克生物向嘉兴银行安吉支行申请的授信 5,000.00 万元 ...

Core Viewpoint - The company has provided guarantees for its subsidiaries to meet their operational funding needs, indicating a strategic move to support growth and development [1] Group 1: Financial Guarantees - The company has issued a joint liability guarantee of 100 million yuan for Hengtong Precision Copper Foil Technology (Deyang) Co., Ltd. and 50 million yuan for Zhejiang Baike Biotechnology Co., Ltd. [1] - The guarantees have a term of three years from the date of debt performance expiration, with no counter-guarantees involved [1] Group 2: Financial Position - As of the announcement date, the total external guarantee balance for the company and its subsidiaries, including this new guarantee, amounts to 437 million yuan [1] - This total represents 12.79% of the audited net assets for the year 2024, with no overdue guarantees reported [1]

Core Viewpoint - Hengtong Holdings has experienced a stock price increase of 68.63% year-to-date, but recent trading shows mixed performance with a slight decline in the last 20 days [1][2] Group 1: Stock Performance - As of November 19, Hengtong's stock price is 4.30 CNY per share, with a market capitalization of 12.79 billion CNY [1] - The stock has seen a trading volume of 69.18 million CNY, with a turnover rate of 0.53% [1] - Year-to-date, the stock has risen by 68.63%, with a recent 5-day increase of 1.18%, a 20-day decline of 5.49%, and a 60-day increase of 35.65% [1] Group 2: Financial Performance - For the period from January to September 2025, Hengtong achieved a revenue of 1.26 billion CNY, representing a year-on-year growth of 38.94% [2] - The net profit attributable to shareholders for the same period was 189 million CNY, showing a slight increase of 0.68% year-on-year [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders has increased by 51.38% to 51,800 [2] - The average number of circulating shares per shareholder is 57,388, which has decreased by 33.94% [2] - Hengtong has distributed a total of 709 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]

Market Overview - The participation fund sector declined by 0.53% on November 14, with Changjiang Securities leading the drop [1] - The Shanghai Composite Index closed at 3990.49, down 0.97%, while the Shenzhen Component Index closed at 13216.03, down 1.93% [1] Individual Stock Performance - Notable gainers included: - Zhongshun Group (Code: 000039) with a closing price of 8.94, up 9.96% [1] - Guomai Technology (Code: 002093) with a closing price of 11.90, up 2.15% [1] - Major decliners included: - Changjiang Securities (Code: 000783) with a closing price of 8.80, down 2.98% [2] - Huatai Securities (Code: 601688) with a closing price of 22.17, down 2.93% [2] Capital Flow Analysis - The participation fund sector experienced a net outflow of 2.136 billion yuan from institutional investors, while retail investors saw a net inflow of 1.242 billion yuan [2] - The overall capital flow indicated that speculative funds had a net inflow of 894 million yuan [2] Detailed Capital Flow by Stock - Key stocks with significant capital flow: - Zhongshun Group had a net inflow of 597 million yuan from institutional investors, but a net outflow of 378 million yuan from speculative funds [3] - Industrial and Commercial Bank of China (Code: 601398) saw a net inflow of 145 million yuan from institutional investors [3] - Other stocks like Northeast Securities (Code: 000686) and Hanhua Technology (Code: 600226) showed mixed capital flows with both inflows and outflows from different investor types [3]

Core Viewpoint - Hengtong Holdings has experienced significant stock price fluctuations in 2023, with a year-to-date increase of 65.10% but a recent decline of 9.66% over the past five trading days [2] Group 1: Stock Performance - As of October 31, Hengtong's stock price rose by 2.18% to 4.21 CNY per share, with a total market capitalization of 12.52 billion CNY [1] - The stock has seen a trading volume of 64.89 million CNY, with a turnover rate of 0.53% [1] - Year-to-date, Hengtong's stock has been on the龙虎榜 (top trading list) once, with a net buy of 48.06 million CNY on August 29 [2] Group 2: Financial Performance - For the period from January to September 2025, Hengtong reported a revenue of 1.262 billion CNY, reflecting a year-on-year growth of 38.94% [2] - The net profit attributable to shareholders for the same period was 189 million CNY, showing a slight increase of 0.68% year-on-year [2] Group 3: Business Overview - Hengtong Holdings, established on May 11, 1999, primarily operates in the production and sales of biological pesticides, veterinary drugs, and feed additives, with a significant focus on electrolytic copper foil, which constitutes 67.62% of its revenue [2] - The company is classified under the public utility sector, specifically in electricity and heat services, and is involved in various concept sectors including lithium batteries and copper foil [2] Group 4: Shareholder Information - As of September 30, 2025, Hengtong had 51,800 shareholders, an increase of 51.38% from the previous period, with an average of 57,388 circulating shares per shareholder, down by 33.94% [2] - The company has cumulatively distributed 709 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]